Diagenode

Distinct and temporary-restricted epigenetic mechanisms regulate human αβ and γδ T cell development


Roels J, Kuchmiy A, De Decker M, et al.

The development of TCRαβ and TCRγδ T cells comprises a step-wise process in which regulatory events control differentiation and lineage outcome. To clarify these mechanisms, we employed RNA-sequencing, ATAC-sequencing and ChIPmentation on well-defined thymocyte subsets that represent the continuum of human T cell development. The chromatin accessibility dynamics show clear stage specificity and reveal that human T cell-lineage commitment is marked by GATA3- and BCL11B-dependent closing of PU.1 sites. A temporary increase in H3K27me3 without open chromatin modifications is unique for β-selection, whereas emerging γδ T cells, which originate from common precursors of β-selected cells, show large chromatin accessibility changes due to strong T cell receptor (TCR) signaling. Furthermore, we unravel distinct chromatin landscapes between CD4+ and CD8+ αβ-lineage cells that support their effector functions and reveal gene-specific mechanisms that define mature T cells. This resource provides a framework for studying gene regulatory mechanisms that drive normal and malignant human T cell development.

Tags
ChIP-seq
Antibody

Share this article

Published
July, 2020

Source

Products used in this publication

  • default alt
    C01011000
    Auto ChIPmentation Kit for Histones
  • cut and tag antibody icon
    C15200152
    H3K4me3 monoclonal antibody
  • ChIP-seq Grade
    C15410174
    H3K27ac polyclonal antibody
  • ChIP-seq Grade
    C15410069
    H3K27me3 polyclonal antibody
  • default alt
    C01011010
    ChIPmentation Kit for Histones
  • Kit icon
    C01011009
    ChIPmentation Kit for Histones

イベント

  • APHL 2024
    Milwaukee, Wisconsin, USA
    May 6-May 9, 2024
  • London Calling 2024
    London, UK
    May 21-May 24, 2024
 すべてのイベントを見る

ニュース

 すべてのニュースを見る


The European Regional Development Fund and Wallonia are investing in your future.

Extension of industrial buildings and new laboratories.


       Site map   |   Contact us   |   Conditions of sales   |   Conditions of purchase   |   Privacy policy   |   Diagenode Diagnostics